Showing results (6311-6320 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 29, 2009
HPLC and MS analysis for the identification and characterisation of peptides presented in the context of the non-classical human leukocytes antigen (HLA) class I molecule HLA-EEnrico Millo, Gianluca DamonteCurrent Pharmaceutical Design|October 29, 2009
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cellsGabriella Pietra, Chiara Romagnani, Lorenzo Moretta, et al.Current Pharmaceutical Design|October 29, 2009
Simultaneous optimization of potency, selectivity and physicochemical properties for cannabinoid CB(2) ligandsKarin Worm, Roland E DolleCurrent Pharmaceutical Design|October 29, 2009
Mast cells: target and source of neuropeptidesF Tore, N TuncelCurrent Pharmaceutical Design|October 29, 2009
Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitorsF Deho, A Gallina, A Salonia, et al.Current Pharmaceutical Design|October 29, 2009
Is there a role for PDE5 inhibitors in the management of male infertility due to defects in testicular or epididymal function?F Dimitriadis, P Tsounapi, M Saito, et al.Current Pharmaceutical Design|October 29, 2009
Recent advances of fluorescent technologies for drug discovery and developmentChiranjib Chakraborty, Chi-Hsin Hsu, Zhi-Hong Wen, et al.Current Pharmaceutical Design|November 14, 2009
Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophreniaMihály Hajós, Bruce N RogersCurrent Pharmaceutical Design|November 21, 2009
Current clinical applications of botulinum toxinDaniel D Truong, Andrea Stenner, Gerhard ReichelPageof 1,008